Harrow, Inc. offers speculative gains from $20s to $30s, with Q4 growth, bullish 2025 revenue guidance, and long-term growth ...

To date, ILM-Blue ® remains the only ILM staining solution approved by the FDA. It is marketed under the brand name ...

Medically reviewed by Danielle Weiss, MD Diabetic macular edema (DME) is a leading cause of vision loss in people with ...

Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products.

ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has ...

ATHENS, Greece — Retinal re-detachment following cataract extraction remains significant in patients who have previously undergone pars plana vitrectomy for retinal detachment, according to a study.

Brazilian researchers conducted a study comparing two treatments for postoperative endophthalmitis. They found that pars ...

The investigators conducted a prospective interventional study to determine the therapeutic anatomic and functional effects ...

We report a case of opacification of a hydrophilic sutureless scleral-fixated Carlevale intraocular lens (IOL) (FIL SSF, Soleko IOL Division) following multiple pars plana vitrectomy surgeries for ...

Vasan Eye Care continues to pave the way for better vision and overall improved quality of life for everyone ...

The visual system is the part of the central nervous system that is required for visual perception – receiving, processing and interpreting visual information to build a representation of the ...